doi: 10.1002/jcsm.12743 58 JensenMRatnerCRudenkoOChristiansenSHSkovLJHundahlCet al
Composition Typically formulated as a combined 10 mg vial, commonly: 5 mg CJC-1295 (No DAC) 5 mg Ipamorelin Total = 10 mg blended peptide content Physical form Lyophilised (freeze-dried) sterile powder Stored in sealed laboratory-grade vial Designed for reconstitution in controlled research environments only Research classification This blend is studied in experimental endocrinology and peptide signalling research , focusing on: Growth hormone pulse regulation GHRH and ghrelin receptor pathway interaction Endocrine signalling dynamics Receptor co-activation and feedback mechanisms Hormonal rhythm and secretion pattern modelling Mechanism overview (research context) This combination pairs two different biological pathways: CJC-1295 (No DAC): a modified growth hormone-releasing hormone (GHRH) analog that stimulates pituitary GH release in a short, pulsatile manner Ipamorelin: a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R1a) to amplify GH pulses Together, they are used in research to model synergistic, dual-pathway GH secretion and study how multiple receptor systems interact Key laboratory interest Researchers commonly use this blend to investigate: Natural-like pulsatile GH signalling patterns Interaction between GHRH and ghrelin systems Endocrine feedback loop behaviour Tissue growth signalling cascades (in vitro / preclinical models) Peptide receptor cross-talk dynamics Stability & handling Lyophilised form improves shelf stability Typically stored frozen before reconstitution (research protocol dependent) After reconstitution, refrigerated conditions are commonly used in lab settings Regulatory status Not approved for human or veterinary use Not a licensed medicinal product Supplied strictly as research chemical / laboratory reagent Intended for qualified research environments only Description Additional information Reviews (1) CJC-1295 (No DAC) + Ipamorelin 10 mg Blend (Lyophilised Research Material) The CJC-1295 (No DAC) + Ipamorelin 10 mg blend is a freeze-dried (lyophilised) dual-peptide research compound supplied for laboratory research only
It has the proven ability to increase GH levels and influence overall body composition and levels of body fat in test subjects
Safety advice Not for use during pregnancy or breastfeeding
Dose and frequency will vary based on individual factors and be determined after a physician consultation, but are normally taken 5-7 times weekly at night before bed as sleep is when most IGF-1 production occurs
In the world of performance enhancement and anti-aging medicine, peptides have emerged as one of the most effective and targeted tools for growth, recovery, and body composition
